Gastrointestinal toxicity of gemtuzumab ozogamicin: real-life data from the AMLCG, SAL, and CELL study groups.
2025-07-08, Blood Advances (10.1182/bloodadvances.2024014570) (online)Barbora Weinbergerová, Marion Subklewe, Christoph Röllig, Karsten Spiekermann, Tobias Herold, Veit L Bücklein, Eva Hoster, Christoph Schliemann, Stefan W Krause, Maher Hanoun, Martina Rudelius, Michael S von Bergwelt-Baildon, Franziska Modemann, Carolin Krekeler, Katja Gutmair, Sabrina Kraus, Ricarda Knabe, Philippe Muller, Julia Marie Unglaub, Jiří Mayer, Martin Kaufmann, Björn Steffen, and Wolfgang G Kunz (?)
This article has not yet been included in any curations.
Comments
There are no comments on this article yet.
You need to login or register to comment.